Comparison of Erector Spinae Plane Block and Intravenous Analgesic in Nefrectomy
NCT ID: NCT04686890
Last Updated: 2021-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2020-12-30
2021-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of External Oblique Intercostal Block Versus Paravertebral Block on Postoperative Pain and Complications in Open Nephrectomy Patients
NCT07071012
Comparison of Erector Spina Plan Block and Trnsversus Abdominis Plan Block in Laparoscopic Nephrectomy: Prospective Randomized Clinical Trial
NCT05913167
Erector Spinae Plane Block for Post-nephrectomy Pain
NCT04537598
Intrathecal Morphine vs. Quadratus Lumborum Block for Pain in Laparoscopic Nephrectomy
NCT06630858
Comparison of Quadratus Lumborum Block and Erector Spina Plane Block in Nephrectomy
NCT04459624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
postoperative opiod (morphine) consumption
patient-controlled analgesia (15 minutes. lock time, 2 ml bolus= total 1 mg morphine intravenously, limited to maximum 4 bolus / per hour )
erector spinea plane block administered preoperative open nephrectomy
erector spinae plane block applied in this group before open nephrectomy
intravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg
intarvenous analgesic administered in this group for analgesia end of the open nephrectomy
peroperative continuous opioid (remifentanil) consumption
continuous remifentanil infusion was given during the whole procedure
erector spinea plane block administered preoperative open nephrectomy
erector spinae plane block applied in this group before open nephrectomy
intravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg
intarvenous analgesic administered in this group for analgesia end of the open nephrectomy
postoperative numerated rating scale
at the 1, 3, 6, 12 and 24 th hour postoperatively - numerated rating scale score was evaluated and recoded as 0= no pain (better), 10: unbearable pain (worse)
erector spinea plane block administered preoperative open nephrectomy
erector spinae plane block applied in this group before open nephrectomy
intravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg
intarvenous analgesic administered in this group for analgesia end of the open nephrectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
erector spinea plane block administered preoperative open nephrectomy
erector spinae plane block applied in this group before open nephrectomy
intravenous analgesic ( 1 mg/kg tramadol + non-steroid antiinflamatuar paracetamol )drug + 10 mg.kg
intarvenous analgesic administered in this group for analgesia end of the open nephrectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing elective nephrectomy
Exclusion Criteria
* pregnancy
* lung disease
* scoliosis
* bleeding disorder
* infection at the manipulation side
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zehra Ipek ARSLAN
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zehra Arslan
Role: PRINCIPAL_INVESTIGATOR
Kocaeli University Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kocaeli University Medical Faculty
Kocaeli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KIA 2020/96
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.